Article
Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer.
Journal of viral hepatitis - 1 Nov 2010
Borentain P, Colson P, Coso D, Bories E, Charbonnier A, Stoppa A M, Auran T, Loundou A, Motte A, Ressiot E, Norguet E, Chabannon C, Bouabdallah R, Tamalet C, Gérolami R
Abstract excerpt
We studied clinical outcome and clinico-virological factors associated with hepatitis B virus reactivation (HBV-R) following cancer treatment in hepatitis B virus surface antigen (HBsAg)-negative/anti-hepatitis B core antibodies (anti-HBcAb)-positive patients. Between 11/2003 and 12/2005, HBV-R occurred in 7/84 HBsAg-negative/anti-HBcAb-positive patients treated for haematological or solid cancer. Virological...
Topics
- Aged
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Agents
- DNA, Viral
- Drug-Related Side Effects and Adverse Reactions
- Female
- Genotype
- Hepatitis B
- Hepatitis B Antibodies
